mynth
11/2025

THERMOSAFE

Acquired by

ARSENAL CAPITAL PARTNERS

UNITED STATES Chemicals & Materials / Packaging & Containers EV 500M - 1.5b USD

Context

Arsenal Capital Partners completed the acquisition of ThermoSafe from Sonoco Products Company. The deal represents a full‑control buy‑out of ThermoSafe, with the seller exiting the cold‑chain packaging segment and simplifying its portfolio around core metal and paper consumer and industrial packaging businesses. The temperature‑controlled packaging business is deeply embedded in the pharmaceutical and biologics value chain, serving high‑value, highly regulated shipments where product integrity and temperature control are critical. Arsenal positions the transaction as a strategic platform play within its middle‑market specialty‑industrial and healthcare vertical, aiming to leverage its prior experience in the packaging and industrial materials sectors to accelerate ThermoSafe’s growth through expanded geographic reach, product‑line innovation, and operational improvements. The firm also plans to support the existing management team led by CEO Russell Grissett, reinforcing continuity while professionalizing governance and commercial capabilities to capture further share in a global cold‑chain packaging market projected to grow at a double‑digit CAGR over the next decade.

THERMOSAFE, which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the average currently observed in the Industry & Manufacturing sector (11.0x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Industry & Manufacturing market trends

Target

ThermoSafe is a specialty industrial company that provides temperature‑controlled packaging systems for the transportation of pharmaceuticals, biologics, vaccines, and clinical supplies. Headquartered in Arlington Heights, Illinois, near Chicago, the group operates additional facilities in France, India, and Brazil, giving it a transatlantic and emerging‑market footprint aligned with global healthcare logistics. The company’s product portfolio includes parcel shippers for single‑ and multi‑dose medications, reusable shippers for repeated cold‑chain use, and bulk transport systems for pallet‑sized, temperature‑assured shipments, all engineered to maintain precise refrigerated, frozen, and controlled room‑temperature conditions throughout the supply chain. ThermoSafe also offers design, testing, and regulatory compliance services through its ISC Labs division, enabling customers to validate and optimize packaging for complex life‑science applications.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples Analysis

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (USD)

Year
Rev
EBITDA
EBIT
2024
LOGIN
LOGIN
LOGIN
2023
LOGIN
LOGIN
LOGIN

Other operations with THERMOSAFE

REFERENCES

Valuation range: EV 500M - 1.5b USD

Revenue range: 150M - 250M USD

EBITDA range: 50M - 100M USD

Note: Detailed and exact financial metrics (Enterprise Value, Revenue, EBITDA, and precise Multiples) are reserved for Mynth community members. Register for free to unlock full data.

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).